Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Ottawa
$27,000.00
Cost Effectiveness Analysis of a Strategy for the Early Diagnosis and Treatment of Obstructive Lung Disease in Canada
FY 2025-26
Summary
Obstructive lung diseases including COPD and asthma are a source of morbidity and cost to the Canadian healthcare system, and it is estimated that 10% of the general population have undiagnosed airflow obstruction. The UCAP trial used a case finding approach to identify symptomatic individuals with undiagnosed COPD or asthma. They were enrolled in a randomized, controlled trial that showed those who received pulmonologist-directed treatment had less subsequent health care utilization for respiratory illness than those who received usual care. The case finding approach and clinical care delivered to those in the intervention group was safe and feasible. The objective of this research is to evaluate the cost effectiveness of the UCAP strategy for the early diagnosis and treatment of obstructive lung disease. Cost effectiveness and cost utility analyses will be undertaken. A Markov model will be used to simulate the long-term impact of case-finding and early diagnosis on health system costs and QALYs over a patient’s lifetime. The model will estimate the incremental cost-effectiveness ratio (ICER), expressed as cost per QALY gained, comparing the intervention to usual care. Base case analysis as well as sensitivity analysis will be conducted to assess the robustness of the results to changes in key inputs such as intervention efficacy, healthcare costs, and utility estimates. If the intervention demonstrates favourable cost-effectiveness, a budget impact analysis will be undertaken to estimate the financial impact of implementing the program at a provincial level. If the UCAP strategy is shown to be cost effective it may have patient, health care system and population level implications for the diagnosis and treatment of undiagnosed obstructive lung disease in Canada.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572764
Name
Magner Katherine M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cost Effectiveness Analysis of a Strategy for the Early Diagnosis and Treatment of Obstructive Lung Disease in Canada
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Asthma; Copd; Cost Effectiveness; Diagnosis; Respiratory Medicine
Abstract
Obstructive lung diseases including COPD and asthma are a source of morbidity and cost to the Canadian healthcare system, and it is estimated that 10% of the general population have undiagnosed airflow obstruction. The UCAP trial used a case finding approach to identify symptomatic individuals with undiagnosed COPD or asthma. They were enrolled in a randomized, controlled trial that showed those who received pulmonologist-directed treatment had less subsequent health care utilization for respiratory illness than those who received usual care. The case finding approach and clinical care delivered to those in the intervention group was safe and feasible. The objective of this research is to evaluate the cost effectiveness of the UCAP strategy for the early diagnosis and treatment of obstructive lung disease. Cost effectiveness and cost utility analyses will be undertaken. A Markov model will be used to simulate the long-term impact of case-finding and early diagnosis on health system costs and QALYs over a patient’s lifetime. The model will estimate the incremental cost-effectiveness ratio (ICER), expressed as cost per QALY gained, comparing the intervention to usual care. Base case analysis as well as sensitivity analysis will be conducted to assess the robustness of the results to changes in key inputs such as intervention efficacy, healthcare costs, and utility estimates. If the intervention demonstrates favourable cost-effectiveness, a budget impact analysis will be undertaken to estimate the financial impact of implementing the program at a provincial level. If the UCAP strategy is shown to be cost effective it may have patient, health care system and population level implications for the diagnosis and treatment of undiagnosed obstructive lung disease in Canada.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Magner, Katherine M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~